Cargando…
Enhanced Oral Bioavailability of Celecoxib Nanocrystalline Solid Dispersion based on Wet Media Milling Technique: Formulation, Optimization and In Vitro/In Vivo Evaluation
Celecoxib (CLX), a selective COX-2 inhibitor, is a biopharmaceutics classification system (BCS) class II drug with its bioavailability being limited by thepoor aqueoussolubility. The purpose of this study was to develop and optimize CLX nanocrystalline(CLX-NC) solid dispersion prepared by the wet me...
Autores principales: | Ding, Zhuang, Wang, Lili, Xing, Yangyang, Zhao, Yanna, Wang, Zhengping, Han, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680726/ https://www.ncbi.nlm.nih.gov/pubmed/31336734 http://dx.doi.org/10.3390/pharmaceutics11070328 |
Ejemplares similares
-
Evaluation of Different Techniques for Size Determination of Drug Nanocrystals: A Case Study of Celecoxib Nanocrystalline Solid Dispersion
por: Kaur, Amanpreet, et al.
Publicado: (2019) -
Novel Colloidal Dispersing Concept in Aqueous Media for Preparation by Wet-Jet Milling Dispersing Method
por: Kato, Haruhisa, et al.
Publicado: (2022) -
Bioavailability of Celecoxib Formulated with Mesoporous Magnesium Carbonate—An In Vivo Evaluation
por: Zardán Gómez de la Torre, Teresa, et al.
Publicado: (2022) -
Enhanced bioavailability of danazol nanosuspensions by wet milling and high-pressure homogenization
por: Kanthamneni, Naveen, et al.
Publicado: (2016) -
Formulation, Characterization, and in Vivo Evaluation of Celecoxib-PVP Solid Dispersion Nanoparticles Using Supercritical Antisolvent Process
por: Ha, Eun-Sol, et al.
Publicado: (2014)